Endocannabinoid System: The Key to a More Human Medicine

Although essential for the body's balance, the endocannabinoid system (ECS) is still underexplored in medical education. It plays a role in regulating vital functions such as mood, pain, sleep, inflammation, and immune response.

Discovered in the early 1990s by scientist Raphael Mechoulam, the ECS is composed of three main elements: endocannabinoids, receptors (CB1 and CB2), and regulatory enzymes.

According to Cannabis Health News, CB1 receptors are concentrated in the central nervous system, while CB2 receptors are distributed throughout the immune system and peripheral parts of the body, a network that directly influences internal balance and physical and emotional well-being.

In other words, understanding the endocannabinoid system means understanding how the body naturally seeks its balance point, impacting everything from pain response to mood and sleep quality.

The Knowledge Still Distant from Clinical Practice

Despite its relevance, the ECS remains absent from most medical and nursing curricula worldwide. A study conducted in Portugal revealed that, among 610 nurses and nursing students, 79.6% recognize the therapeutic benefits of cannabis, but over 70% have never heard of the endocannabinoid system.

This gap in education creates a mismatch: professionals who want to understand the therapeutic potentials of cannabis but do not have access to the biological knowledge that supports its clinical application. This lack of information can compromise the quality of care provided, especially in cases of patients with chronic or difficult-to-control conditions.

There is also a hypothesis raised by researchers, cited by Cannabis Health News, that diseases such as fibromyalgia, migraines, and irritable bowel syndrome may be associated with an “endocannabinoid system deficiency.” In these cases, the ECS may not produce enough endocannabinoids, impairing its regulatory function.

Knowledge that Transforms Care

Beyond science, understanding the ECS means humanizing care. Professionals who recognize this system begin to look at the patient more broadly, considering the biological, emotional, and even social factors that influence their balance.

The therapeutic use of cannabinoids should not be seen as an isolated solution but as part of an integrated approach, including lifestyle, emotional support, and responsible medical monitoring.

The path to progress, as highlighted by Cannabis Health News, lies in continuous education and interdisciplinary dialogue. Promoting courses, debates, and exchanges among healthcare professionals can be the first step in reducing ignorance and bringing science, practice, and empathy closer together.

In a scenario where more and more patients seek cannabis-based therapies, understanding the endocannabinoid system opens up space for a more comprehensive and compassionate medicine.

With information from Cannabis Health News.